Published in J Nutr Health Aging on May 17, 2007
Brain foods: the effects of nutrients on brain function. Nat Rev Neurosci (2008) 2.45
Long-term multivitamin supplementation and cognitive function in men: a randomized trial. Ann Intern Med (2013) 2.39
A randomized trial of beta carotene supplementation and cognitive function in men: the Physicians' Health Study II. Arch Intern Med (2007) 2.20
Epidemiologic studies of modifiable factors associated with cognition and dementia: systematic review and meta-analysis. BMC Public Health (2014) 1.38
Reactive oxygen species in the regulation of synaptic plasticity and memory. Antioxid Redox Signal (2010) 1.37
Neighborhood socioeconomic status and cognitive function in women. Am J Public Health (2011) 1.22
Free radical-mediated damage to brain in Alzheimer's disease and its transgenic mouse models. Free Radic Biol Med (2008) 1.19
Diet quality is associated with better cognitive test performance among aging men and women. J Nutr (2009) 1.11
Prospective study of Dietary Approaches to Stop Hypertension- and Mediterranean-style dietary patterns and age-related cognitive change: the Cache County Study on Memory, Health and Aging. Am J Clin Nutr (2013) 1.11
Mitochondria and antioxidant targeted therapeutic strategies for Alzheimer's disease. J Alzheimers Dis (2010) 0.95
Better cognitive performance in elderly taking antioxidant vitamins E and C supplements in combination with nonsteroidal anti-inflammatory drugs: the Cache County Study. Alzheimers Dement (2008) 0.91
Comparisons of plasma/serum micronutrients between Okinawan and Oregonian elders: a pilot study. J Gerontol A Biol Sci Med Sci (2010) 0.91
Antioxidants have a rapid and long-lasting effect on neuritic abnormalities in APP:PS1 mice. Neurobiol Aging (2009) 0.91
Total antioxidant capacity of diet in relation to cognitive function and decline. Am J Clin Nutr (2010) 0.89
A critical review of vitamin C for the prevention of age-related cognitive decline and Alzheimer's disease. J Alzheimers Dis (2012) 0.86
Diet and neurocognition: review of evidence and methodological considerations. Curr Aging Sci (2010) 0.86
The association of antioxidants and cognition in the Nurses' Health Study. Am J Epidemiol (2012) 0.85
The Cache County Study on Memory in Aging: factors affecting risk of Alzheimer's disease and its progression after onset. Int Rev Psychiatry (2013) 0.84
Antioxidant nutrients and age-related cognitive decline: a systematic review of population-based cohort studies. Eur J Nutr (2013) 0.84
Medicinal chemistry of the epigenetic diet and caloric restriction. Curr Med Chem (2013) 0.83
Association between food and nutrient intakes and cognitive capacity in a group of institutionalized elderly people. Eur J Nutr (2009) 0.81
Genetic aspects of behavioral neurotoxicology. Neurotoxicology (2009) 0.79
Antioxidant and astroprotective effects of a Pulicaria incisa infusion. Oxid Med Cell Longev (2012) 0.79
Dietary antioxidant intake and its association with cognitive function in an ethnically diverse sample of US adults. Psychosom Med (2015) 0.78
Brain tocopherols related to Alzheimer's disease neuropathology in humans. Alzheimers Dement (2014) 0.78
Tualang honey improves memory performance and decreases depressive-like behavior in rats exposed to loud noise stress. Noise Health (2015) 0.78
Tualang Honey Attenuates Noise Stress-Induced Memory Deficits in Aged Rats. Oxid Med Cell Longev (2016) 0.75
Resveratrol: An Antiaging Drug with Potential Therapeutic Applications in Treating Diseases. Pharmaceuticals (Basel) (2009) 0.75
Vitamin C Status and Cognitive Function: A Systematic Review. Nutrients (2017) 0.75
Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome. JAMA (2001) 5.13
APOE-epsilon4 count predicts age when prevalence of AD increases, then declines: the Cache County Study. Neurology (1999) 4.37
Mental and behavioral disturbances in dementia: findings from the Cache County Study on Memory in Aging. Am J Psychiatry (2000) 4.23
Intranasal insulin improves cognition and modulates beta-amyloid in early AD. Neurology (2007) 4.14
Statin therapy is associated with reduced neuropathologic changes of Alzheimer disease. Neurology (2007) 3.67
Documented head injury in early adulthood and risk of Alzheimer's disease and other dementias. Neurology (2000) 3.61
Specificity, sensitivity, and predictive value of apolipoprotein-E genotyping for sporadic Alzheimer's disease. Lancet (1996) 3.58
Nitric oxide synthase and neuronal NADPH diaphorase are identical in brain and peripheral tissues. Proc Natl Acad Sci U S A (1991) 3.22
Development of the EURO-D scale--a European, Union initiative to compare symptoms of depression in 14 European centres. Br J Psychiatry (1999) 3.13
Neuropathological and neuropsychological changes in "normal" aging: evidence for preclinical Alzheimer disease in cognitively normal individuals. J Neuropathol Exp Neurol (1998) 2.92
A 24-year follow-up of body mass index and cerebral atrophy. Neurology (2004) 2.91
FDG PET imaging in patients with pathologically verified dementia. J Nucl Med (2000) 2.70
A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer's disease. Pharmacogenomics J (2009) 2.66
Neuropsychiatric disturbance in Alzheimer's disease clusters into three groups: the Cache County study. Int J Geriatr Psychiatry (2001) 2.63
Nitric oxide synthase protein and mRNA are discretely localized in neuronal populations of the mammalian CNS together with NADPH diaphorase. Neuron (1991) 2.60
Does NSAID use modify cognitive trajectories in the elderly? The Cache County study. Neurology (2007) 2.56
Naproxen and celecoxib do not prevent AD in early results from a randomized controlled trial. Neurology (2007) 2.54
Incidence of AD may decline in the early 90s for men, later for women: The Cache County study. Neurology (2002) 2.52
Burden of illness and suicide in elderly people: case-control study. BMJ (2002) 2.51
The Nun study: clinically silent AD, neuronal hypertrophy, and linguistic skills in early life. Neurology (2009) 2.33
A 40-year follow-up of patients with obsessive-compulsive disorder [see commetns]. Arch Gen Psychiatry (1999) 2.31
Onset of terminal decline in cognitive abilities in individuals without dementia. Neurology (2008) 2.24
High total cholesterol levels in late life associated with a reduced risk of dementia. Neurology (2005) 2.07
Vascular factors predict rate of progression in Alzheimer disease. Neurology (2007) 2.06
APOE genotype predicts when--not whether--one is predisposed to develop Alzheimer disease. Nat Genet (1998) 2.05
Prevalence of depression and its treatment in an elderly population: the Cache County study. Arch Gen Psychiatry (2000) 1.97
Occupational exposure to pesticides increases the risk of incident AD: the Cache County study. Neurology (2010) 1.95
Postpartum thiamine deficiency in a Karen displaced population. Am J Clin Nutr (2001) 1.90
NSAID use and dementia risk in the Cardiovascular Health Study: role of APOE and NSAID type. Neurology (2007) 1.88
Tau and Abeta42 in cerebrospinal fluid from healthy adults 21-93 years of age: establishment of reference values. Clin Chem (2001) 1.87
Depressive symptoms and risk of stroke: the Rotterdam Study. J Neurol Neurosurg Psychiatry (2008) 1.84
The association of psychotropic medication use with the cognitive, functional, and neuropsychiatric trajectory of Alzheimer's disease. Int J Geriatr Psychiatry (2012) 1.82
Serum cholesterol and risk of Alzheimer disease: a community-based cohort study. Neurology (2005) 1.75
Depression symptoms in late life assessed using the EURO-D scale. Effect of age, gender and marital status in 14 European centres. Br J Psychiatry (1999) 1.75
Conversion to dementia from mild cognitive disorder: the Cache County Study. Neurology (2006) 1.75
Dietary fat and postmenopausal breast cancer. J Natl Cancer Inst (1992) 1.73
Determinants of vascular dementia in the Cardiovascular Health Cognition Study. Neurology (2005) 1.70
The 32-year relationship between cholesterol and dementia from midlife to late life. Neurology (2010) 1.64
Little evidence for different phenomenology in poststroke depression. Acta Psychiatr Scand (2010) 1.50
A population-based study on the incidence of dementia disorders between 85 and 88 years of age. J Am Geriatr Soc (1996) 1.49
Apolipoprotein E epsilon 4 allele and hippocampal volume in twins with normal cognition. Neurology (1997) 1.47
Enhanced cognitive performance with estrogen use in nondemented community-dwelling older women. J Am Geriatr Soc (1999) 1.47
Body mass index and white matter lesions in elderly women. An 18-year longitudinal study. Int Psychogeriatr (2004) 1.46
Rapid brain autopsy. The Joseph and Kathleen Bryan Alzheimer's Disease Research Center experience. Arch Pathol Lab Med (1997) 1.46
No advantage of A beta 42-lowering NSAIDs for prevention of Alzheimer dementia in six pooled cohort studies. Neurology (2008) 1.45
Age effects of coronary artery bypass graft on cognitive status change among elderly male twins. Neurology (2004) 1.44
Dementia diagnoses from clinical and neuropsychological data compared: the Cache County study. Neurology (2000) 1.44
Incidence of hypertension and stroke in relation to body fat distribution and other risk factors in older women. Stroke (1990) 1.42
Genome-wide scan of bipolar disorder in 65 pedigrees: supportive evidence for linkage at 8q24, 18q22, 4q32, 2p12, and 13q12. Mol Psychiatry (2003) 1.42
The prognosis and incidence of social phobia in an elderly population. A 5-year follow-up. Acta Psychiatr Scand (2010) 1.41
A twin study of late-onset depression and apolipoprotein E epsilon 4 as risk factors for Alzheimer's disease. Biol Psychiatry (1997) 1.39
Comparison of Lewy body variant of Alzheimer's disease with pure Alzheimer's disease: Consortium to Establish a Registry for Alzheimer's Disease, Part XIX. Neurology (1999) 1.37
Contrasting immunohistochemical localizations in rat brain of two novel K+ channels of the Shab subfamily. J Neurosci (1993) 1.35
Suicidal feelings in the last year of life in elderly people who commit suicide. Lancet (1999) 1.35
High brain densities of the immunophilin FKBP colocalized with calcineurin. Nature (1992) 1.34
Reduced prevalence of AD in users of NSAIDs and H2 receptor antagonists: the Cache County study. Neurology (2000) 1.33
Dementia: the leading predictor of death in a defined elderly population: the Cache County Study. Neurology (2004) 1.29
Association of transforming growth-factor alpha gene polymorphisms with nonsyndromic cleft palate only (CPO). Am J Hum Genet (1993) 1.27
Effects of cardiovascular medications on rate of functional decline in Alzheimer disease. Am J Geriatr Psychiatry (2008) 1.27
Adiposity indicators and dementia over 32 years in Sweden. Neurology (2009) 1.26
Cerebral infarcts in patients with autopsy-proven Alzheimer's disease: CERAD, part XVIII. Consortium to Establish a Registry for Alzheimer's Disease. Neurology (1998) 1.26
Advances in the prevention of Alzheimer's disease and dementia. J Intern Med (2014) 1.23
Blood pressure and risk of dementia: results from the Rotterdam study and the Gothenburg H-70 Study. Dement Geriatr Cogn Disord (2001) 1.23
Physical health and depressive symptoms in older Europeans. Results from EURODEP. Br J Psychiatry (2005) 1.21
Depression, cerebral atrophy, cognitive performance and incidence of dementia. Population study of 85-year-olds. Br J Psychiatry (1999) 1.18
Identification of a novel panel of cerebrospinal fluid biomarkers for Alzheimer's disease. Neurobiol Aging (2007) 1.17
Changes in drug treatment in the elderly between 1971 and 2000. Eur J Clin Pharmacol (2003) 1.15
Using genetics to enable studies on the prevention of Alzheimer's disease. Clin Pharmacol Ther (2012) 1.14
Protein analysis in cerebrospinal fluid. II. Reference values derived from healthy individuals 18-88 years of age. Eur Neurol (1993) 1.13